Recently, the Multidisciplinary Association for Psychedelic Studies (MAPS) has received FDA-approval for research into the possible benefits of MDMA in the treatment of post-traumatic stress disorder. Such research could greatly benefit American veterans returning from Iraq and Afghanistan.<ref>http://www.maps.org/mdma/</ref>
+
Recently, the Multidisciplinary Association for Psychedelic Studies (MAPS) has received FDA-approval for research into the possible benefits of MDMA in the treatment of post-traumatic stress disorder. <ref>http://www.maps.org/mdma/</ref>